References
- Birge SJ. The use of estrogen in older women. Clin Geriatr Med 2003; 19(3):617–627, viii.
- Jewelewicz R. New developments in topical estrogen therapy. Fertil Steril 1997; 67(1):1–12.
- Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC, Place VA. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol 1985; 152(8): 1099–1106.
- Shaw JE, Prevo ME, Amkraut AA. Testing of controlled-release transdermal dosage forms. Product development and clinical trials. Arch Dermatol 1987; 123(11):1548–1556.
- Akhila V, Pratapkumar. A comparison of transdermal and oral HRT for menopausal symptom control. Int J Fertil Womens Med 2006; 51(2):64–69.
- Sumino H, Ichikawa S., Kasama S., Takahashi T., Kumakura H., Takayama Y., Kanda T., Kurabayashi M. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women. Atherosclerosis 2006; 189(2):436–442.
- Vehkavaara S, Hokala-Ala-Pretila T., Virkamaki A., Bergholm R., Ehnholm C., Hovatta O., Taskinen M.R., Yki-Yarvinen H. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation 2000; 102(22):2687–2693.
- Vrablik M, Fait T., Kovar J., Poledne R., Ceska R. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Metabolism 2008; 57(8):1088–1092.
- Crank J. Mathematics of Diffusion. Oxford, UK: Oxford University Press. 1975:47–48.